Hubungan Efek Samping Obat Anti Tuberkulosis Dengan Kualitas Hidup Pasien TB Di Puskesmas Banyuglugur Situbondo
DOI:
https://doi.org/10.59581/diagnosa-widyakarya.v1i4.1333Keywords:
Tuberculosis, Anti-Tuberculosis Drugs, Side Effects, Quality of LifeAbstract
Tuberculosis (TB) is a disease that is ranked 10th with the highest number of deaths. Side effects caused by Anti-Tuberculosis Drugs (OAT) are often experienced by TB patients and result in physical disorders that reduce the quality of life of TB patients. This study aims to analyze the relationship between OAT side effects and the quality of life of TB patients at the Banyuglugur Community Health Center
The research design in the study used a cross sectional approach. The population of this study was all TB patients in the Banyuglugur health center working area who underwent treatment for <6 months according to the inclusion criteria in January 2022 - May 2023, totaling 40 people using the Total Sampling sampling technique. Data were collected using a questionnaire on OAT side effects and quality of life. The analytical test used was the Spearman Rank test.
The results of this study showed that the side effects of OAT in 27 TB patients (67.5%) were severe and the quality of life of 31 TB patients (77.5%) was poor. The results of the analysis show a p value of .001 (smaller than 0.05), so there is a significant linear relationship between the OAT side effect variable and the quality of life of TB patients at the Banyuglugur Community Health Center.
This research shows that the side effects experienced by TB sufferers, both mild and severe, greatly affect the quality of life of TB patients. Health workers must always carry out routine monitoring of OAT side effects experienced by TB sufferers and treat them as soon as possible so that they do not affect the quality of life of TB patients in terms of physical, nutritional or psychological aspects in order to prevent them from dropping out of treatment.
References
Andareto, obi., 2015. Penyakit Menular: mengetahui macam-macam penyakit yang dapat menular. Jakarta: Pustaka Ilmu Semesta.
Alsagaff, Hood, dkk., 2010. Dasar-dasar Ilmu Penyakit Paru, Edisi Ke 2. Surabaya: Airlangga University Press.
Al-jauziyah, Ibnul Qayyim., 2012. Sistem Kedokteran Nabi. Dinas Utama: Semarang.Badan POM RI. Pedoman Monitoring Efek Samping Obat (MESO) Bagi Tenaga Kesehatan.
Bennett's, dkk., 2010. principles and practice of infectious diseases (7th ed.). Philadelphia, PA: Churchill Livingstone/Elsevier, h 250.ISBN 978-0-443-06839-3. Carol, MW, et al. “Frequency of adverse Reactions to first-and Second-Line AntiTuberculosis Chemotherapy in a Korean Cohort”. Int J Tuberc. LungDis: off. J. Int. Union against Tuberc. And Lung Dis. 2012: h 7.
Departemen Kesehatan RI., 2011. Pedoman Penanggulangan Tuberkulosis. Jakarta:Indonesia.
Dinkes Sulsel., 2013. Rekapitulisasi Laporan Hasil P2-TB Paru melalui LaporanTribulan TB.07. Makassar: Dinkes Sulsel.
Kunst H, Khan KS., 2010. Age-related risk of hepatotoxicity in the treatment of latent tuberculosis infection : a systematic review. International Journal of Tuberculosis and Lung Disease.14(11):1374-81
Kemenkes RI. Pedoman Nasional Penanggulangan Tuberkulosis., 2014. Diaksespada http://www.tbindonesia.or.id/opendir/Buku/bpn p-tb 2014.pdf.
KEMENKES RI., 2020. Profil Kesehatan Indonesia 2020. Jakarta: Kementrian Kesehatan RI.
Kurniawati F, Sulaiman SAS, and Gillani WS., 2012. “Adverse Drug Reactions of Patients Anti-tuberculosis Drug Among Tuberculosis Patients Treated in Chest Clinic”. International Journal of Pharmacy & Life Scienses 3 (1) : h 1331-1338
Manalu, H.S.P., 2010. “Faktor-Faktor yang Mempengaruhi Kejadian TB Paru dan Upaya Penanggulangannya”. Jurnal Ekologi Kesehatan Vol. 9 No. 4, Desember 2010: 1340- 1346.
Makassar”, Journal of Agromedicine and Medical Sciences, Vol 3 no 1.2017: h 19.
Nursalam., 2014. Metodologi Penelitian Keperawatan: Pendekatan Praktis Edisi 3. Edisi 3. Jakarta: Salemba Medika.
Notoadmodjo, S., 2003. Pendidikan dan Perilaku Kesehatan. Jakarta: Rineka.
